TotalMarketCap

Seaport Therapeutics

SPTXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.089 B

$20.34 -2.96%

Close of 6 Nov 2026

As of 6 Nov 2026, Seaport Therapeutics (SPTX) has a market capitalization of $1.09B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

53,530,550

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #141VerastemVSTM$1.15B
  2. #142COMPASS PathwaysCMPS$1.11B
  3. #143Seaport TherapeuticsSPTX$1.09B
  4. #144Janux TherapeuticsJANX$985.5M
  5. #145HarrowHROW$975.1M

What if Seaport Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$527,490.82

Per share 25,934× higher

Bitcoin $1.53T

$28,541.61

Per share 1,403× higher

Apple $5.02T

$93,699.44

Per share 4,607× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Seaport Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.